SLC16A1 and pancreatic neoplasm: To address the excess of acid products, such as lactate, from aerobic glycolysis, pancreatic cancer cells robustly express monocarboxylate transporter 1 (MCT1), MCT4 and CD147 on the plasma membrane to accelerate lactate flux [47–49].